BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34949766)

  • 21. Immunoexpression of SDHB, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study.
    Karatay H; Ozluk Y; Dogan MA; Erdem S; Kilicaslan I
    Ann Diagn Pathol; 2021 Oct; 54():151788. PubMed ID: 34246177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
    Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
    Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; CompƩrat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
    Xia QY; Wang XT; Fang R; Wang Z; Zhao M; Chen H; Chen N; Teng XD; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2020 Apr; 44(4):477-489. PubMed ID: 31764220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
    Tsai TH; Lee WY
    Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.
    Szymanski M; Rusetska N; Jancewicz I; Armatowska A; Ligaj M; Chrzan A; Hincza K; Kowalik A; Mika P; Kisiel M; Zolnierek J; Kosior J; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
    Oncologist; 2021 Sep; 26(9):e1652-e1655. PubMed ID: 34003534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
    Mason EF; Hornick JL
    Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.
    CaliĆ³ A; Grignon DJ; Stohr BA; Williamson SR; Eble JN; Cheng L
    Mod Pathol; 2017 Mar; 30(3):407-415. PubMed ID: 27910947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
    Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
    Ozluk Y; Taheri D; Matoso A; Sanli O; Berker NK; Yakirevich E; Balasubramanian S; Ross JS; Ali SM; Netto GJ
    Hum Pathol; 2015 Dec; 46(12):1951-5. PubMed ID: 26476567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
    Miettinen M; Lasota J
    Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
    Ricketts CJ; Shuch B; Vocke CD; Metwalli AR; Bratslavsky G; Middelton L; Yang Y; Wei MH; Pautler SE; Peterson J; Stolle CA; Zbar B; Merino MJ; Schmidt LS; Pinto PA; Srinivasan R; Pacak K; Linehan WM
    J Urol; 2012 Dec; 188(6):2063-71. PubMed ID: 23083876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.
    Williamson SR; Hornick JL; Eble JN; Gupta NS; Rogers CG; True L; Grignon DJ; Cheng L
    Hum Pathol; 2018 May; 75():10-15. PubMed ID: 29180251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Succinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer.
    Kodare D; Menon S; Prakash G; Desai S
    Indian J Cancer; 2023 Oct; 60(4):583-585. PubMed ID: 38189645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.